Pain · people with facioscapulohumeral muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue · people with facioscapulohumeral muscular dystrophy
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Withdrawals due to adverse events · people with facioscapulohumeral muscular dystrophy
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Aerobic capacity · children and adolescents with juvenile dermatomyositis
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Time‐scored functional assessments of muscle performance: distance walked · children and adolescents with juvenile dermatomyositis
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Quality of life · children and adolescents with juvenile dermatomyositis
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Pain · children and adolescents with juvenile dermatomyositis
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Fatigue · children and adolescents with juvenile dermatomyositis
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Withdrawals due to adverse events · children and adolescents with juvenile dermatomyositis
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Muscle strength · children and adults with SMA type 3
1 finding from 1 review
Change from baseline in 6MWT (metres) · children and adults with SMA type 3
1 finding from 1 review
Cardiopulmonary exercise capacity · children and adults with SMA type 3
1 finding from 1 review
Functional performance · children and adults with SMA type 3
1 finding from 1 review
Fatigue In children, · children and adults with SMA type 3
1 finding from 1 review
Physical activity ‐ change from baseline · children and adults with SMA type 3
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life In children, · children and adults with SMA type 3
1 finding from 1 review
Serious adverse events, i.e. serious enough to require withdrawal of the treatment · children and adults with SMA type 3
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients with Chronic CGH
Chronic CGH: Cervical/Scapulothoracic Strengthening with Endurance… showed no clear difference in pain Intensity: VAS 0 no pain to 10 worst pain ( compared with NO INTERVENTION (moderate certainty).
1 finding from 1 review
Function: NPNPQ 0% no disability to 100% maximum disability ( · patients with Chronic CGH
Chronic CGH: Cervical/Scapulothoracic Strengthening with Endurance… showed no clear difference in function: NPNPQ 0% no disability to 100% maximum disability ( compared with NO INTERVENTION (moderate certainty).
1 finding from 1 review
Global Perceived Effect · patients with Chronic CGH
Chronic CGH: Cervical/Scapulothoracic Strengthening with Endurance… showed no clear difference in global Perceived Effect: VAS 0 to 100 ( compared with NO INTERVENTION (moderate certainty).
1 finding from 1 review